These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26759327)

  • 1. New molecular insights in diabetic nephropathy.
    Checheriţă IA; Manda G; Hinescu ME; Peride I; Niculae A; Bîlha Ş; Grămăticu A; Voroneanu L; Covic A
    Int Urol Nephrol; 2016 Mar; 48(3):373-87. PubMed ID: 26759327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes.
    Manda G; Checherita AI; Comanescu MV; Hinescu ME
    Mediators Inflamm; 2015; 2015():604208. PubMed ID: 26491232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible role of glutathione-S-transferase activity in diabetic nephropathy.
    Tesauro M; Nisticò S; Noce A; Tarantino A; Marrone G; Costa A; Rovella V; Di Cola G; Campia U; Lauro D; Cardillo C; Di Daniele N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):129-33. PubMed ID: 25816416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Nephropathy - possibilities of early laboratory diagnostics and course prediction (review of literature).
    Popykhova EB; Ivanov AN; Stepanova TV; Lagutina DD; Savkina AA
    Klin Lab Diagn; 2021 Oct; 66(10):593-602. PubMed ID: 34665945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress in diabetic kidney disease.
    Hakim FA; Pflueger A
    Med Sci Monit; 2010 Feb; 16(2):RA37-48. PubMed ID: 20110930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and its association with TNF-α-308 G/C and IL-1α-889 C/T gene polymorphisms in patients with diabetes and diabetic nephropathy.
    Dabhi B; Mistry KN
    Gene; 2015 May; 562(2):197-202. PubMed ID: 25732517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward.
    Blumenthal SS
    Postgrad Med; 2011 Nov; 123(6):166-79. PubMed ID: 22104465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients.
    Hojs R; Ekart R; Bevc S; Hojs N
    Nephron; 2016; 133(3):159-62. PubMed ID: 27344598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
    Nangaku M; Izuhara Y; Usuda N; Inagi R; Shibata T; Sugiyama S; Kurokawa K; van Ypersele de Strihou C; Miyata T
    Nephrol Dial Transplant; 2005 Dec; 20(12):2661-9. PubMed ID: 16188903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokines in diabetic nephropathy.
    Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.
    Thongboonkerd V
    Contrib Nephrol; 2008; 160():37-52. PubMed ID: 18401160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diabetic nephropathy: Recent progress and future perspective.
    Ahmad J
    Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
    Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
    Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.
    Lv J; Wu Y; Mai Y; Bu S
    J Diabetes Res; 2020; 2020():3960857. PubMed ID: 32656264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.